No new safety signals in ofatumumab open-label data

Trial

ALITHIOS, ASCLEPIOS I, ASCLEPIOS II, APLIOS

Conference

MS Virtual 2020

25 November, 2020 16:57

Two trials comparing relapsing MS treatments

Presented By

Dr L. Kappos & Dr T. Sprenger

Trial

Phase 3, OPTIMUM, ASCLEPIOS

Conference

EAN 2020

10 September, 2020 12:21

Trial

Phase 3, ASCLEPIOS

Conference

ECTRIMS 2019

8 November, 2019 12:08